A COMPARISON OF HTA RECOMMENDATIONS ISSUED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND (AHTAPOL) AND NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE) IN THE UK - CONSIDERATION OF SOCIAL IMPLICATIONS IN HTA

被引：0

作者：

Ceglowska, U. ^{[1
]}

Kolasa, K. ^{[1
]}

Hermanowski, T. ^{[1
]}

机构：

[1] Med Univ Warsaw, Dept Pharmacoecon, Warsaw, Poland

来源：

VALUE IN HEALTH | 2011年 / 14卷 / 07期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A355 / A355

页数：1

共 50 条

[1] A COMPARISON OF HTA RECOMMENDATIONS FOR CANCER TREATMENT TECHNOLOGIES PUBLISHED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT (AHTAPOL) AND NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE)
Kiljan, A.
Kolasa, K.
Hermanowski, T.
[J]. VALUE IN HEALTH, 2010, 13 (07) : A280 - A281
[2] A COMPARISON OF HTA RECOMMENDATIONS ISSUED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT (AHTAPOL) IN POLAND AND THE SCOTTISH MEDICINES CONSORTIUM (SMC)
Kolasa, K.
[J]. VALUE IN HEALTH, 2009, 12 (07) : A250 - A250
[3] THE INCREASING USE AND ACCEPTANCE OF ALTERNATIVE STATISTICAL APPROACHES TO INDIRECT COMPARISON IN THE NATIONAL INSTITUTE OF HEALTH AND CARE EXCELLENCE (NICE) HEALTH TECHNOLOGY ASSESSMENT (HTA) SUBMISSION PROCESS
Pooley, N.
Marjenberg, Z.
Embleton, N.
Langham, S.
[J]. VALUE IN HEALTH, 2019, 22 : S814 - S814
[4] ULTRA-ORPHAN MEDICINAL PRODUCTS ASSESSMENT: COMPARISON OF THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) AND THE INSTITUTE OF CLINICAL AND ECONOMIC REVIEW (ICER) HTA FRAMEWORKS
Dusza, M.
Kloc, K.
Remuzat, C.
Francois, C.
Toumi, M.
[J]. VALUE IN HEALTH, 2019, 22 : S859 - S859
[5] CLINICAL EXPERT OPINION IN HEALTH TECHNOLOGY ASSESSMENT SUBMISSIONS TO A NATIONAL HTA AGENCY IN IRELAND
OCallaghan, J.
Tilson, L.
Mccullagh, L.
Barry, M.
[J]. VALUE IN HEALTH, 2022, 25 (12) : S311 - S311
[6] HTA PROCEDURES IN DRUG REIMBURSEMENT PROCESS IN POLAND. EVOLUTION OF RECOGNITION THE ROLE OF AGENCY OF HEALTH TECHNOLOGY ASSESSMENT (AHTAPOL) BY POLICY MAKERS
Krol, Z. J.
Matusewicz, W.
Musialowicz, A.
[J]. VALUE IN HEALTH, 2009, 12 (03) : A202 - A203
[7] National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease
Fay Chinnery
Gemma Bashevoy
Amanda Blatch-Jones
Lisa Douet
Sarah Puddicombe
James Raftery
[J]. Trials, 19
[8] TRENDS IN THE USE OF PATIENT ACCESS SCHEMES AND COMMERCIAL ACCESS ARRANGEMENTS IN HEALTH TECHNOLOGY ASSESSMENTS (HTA) BY THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)
Hall, D.
Christodoulou, J.
[J]. VALUE IN HEALTH, 2019, 22 : S609 - S609
[9] National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease
Chinnery, Fay
Bashevoy, Gemma
Blatch-Jones, Amanda
Douet, Lisa
Puddicombe, Sarah
Raftery, James
[J]. TRIALS, 2018, 19
[10] A review of Health Technology Assessment (HTA) recommendations for drug therapies issued between 2007 and 2009 and their impact on policymaking processes in Poland
Kolasa, Katarzyna
Schubert, Sebastian
Manca, Andrea
Hermanowski, Tadeusz
[J]. HEALTH POLICY, 2011, 102 (2-3) : 145 - 151

← 1 2 3 4 5 →